Clinical Evaluation of Cordio App in Adult ADHF Patients
Sponsored by Cordio Medical
About this trial
Last updated 4 years ago
Study ID
CA001
Status
Completed
Type
Observational
Placebo
No
Accepting
18+ Years
All
Trial Timing
Ended 4 years ago
What is this trial about?
Observational study on ADHF patients at one site in Israel. After signing informed
consent and undergoing screening assessments, eligible patients will record sentences
into a smartphone. The app will upload the vocal data to the sponsor's servers for
analysis. The patient will record at hospital: admittion, release. Before hospital
release, if applicable and upon patient agrreement, an app will be installed in a
smartphone in order to continue the recording at home.
What are the participation requirements?
Inclusion Criteria
- Diagnosis of ADHF (pulmonary congestion)
- Known diagnosis of HF, with either preserved or reduced LVEF.
- 18+ years old.
- Able to understand and provide written informed consent.
Exclusion Criteria
- Subjects unable to comply with the daily use of the application due to mental disorders.
- GFR <25 ml/min who are non-responsive to diuretic therapy or who are on chronic renal dialysis.
- Subjects with congenital heart disease or mechanical right heart valve(s).
- Airway and lung infection and Sepsis
- Patients with severe alcohol or drug use.
- Women who are pregnant or lactating.